1. Market Research
  2. > Healthcare
  3. > Pathology Market Trends
  4. > Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Global Clinical Trials Review, H2, 2014

Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Global Clinical Trials Review, H2, 2014

Summary

GlobalData's clinical trial report, “Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Global Clinical Trials Review, H2, 2014" provides data on the Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE). It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE). This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Global Clinical Trials Review, H2, 2014
Table of Contents

Introduction 6
Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Top Countries Contributing to Clinical Trials in Middle East and Africa 12
Clinical Trials by G7 Countries: Proportion of Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) to Immunology Clinical Trials 13
Clinical Trials by Phase in G7 Countries 14
Clinical Trials in G7 Countries by Trial Status 15
Clinical Trials by Phase 16
In Progress Trials by Phase 17
Clinical Trials by Trial Status 18
Clinical Trials by End Point Status 19
Unaccomplished Trials of Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) 20
Subjects Recruited Over a Period of Time 21
Clinical Trials by Sponsor Type 22
Prominent Sponsors 23
Top Companies Participating in Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics Clinical Trials 24
Prominent Drugs 25
Clinical Trial Profiles 26
Clinical Trial Overview of Top Companies 26
Celgene Corporation 26
Clinical Trial Overview of Celgene Corporation 26
Astion Pharma A/S 27
Clinical Trial Overview of Astion Pharma A/S 27
Amgen Inc. 28
Clinical Trial Overview of Amgen Inc. 28
Rigel Pharmaceuticals, Inc. 29
Clinical Trial Overview of Rigel Pharmaceuticals, Inc. 29
Immunomedics, Inc. 30
Clinical Trial Overview of Immunomedics, Inc. 30
Clinical Trial Overview of Top Institutes / Government 31
Department of Health, South Africa 31
Clinical Trial Overview of Department of Health, South Africa 31
Florida Academic Dermatology Centers 32
Clinical Trial Overview of Florida Academic Dermatology Centers 32
The Newcastle upon Tyne Hospitals NHS Foundation Trust 33
Clinical Trial Overview of The Newcastle upon Tyne Hospitals NHS Foundation Trust 33
Shahid Beheshti University of Medical Sciences 34
Clinical Trial Overview of Shahid Beheshti University of Medical Sciences 34
The Cleveland Clinic 35
Clinical Trial Overview of The Cleveland Clinic 35
Wake Forest University 36
Clinical Trial Overview of Wake Forest University 36
New York University School of Medicine 37
Clinical Trial Overview of New York University School of Medicine 37
National Cancer Institute 38
Clinical Trial Overview of National Cancer Institute 38
University of Leipzig 39
Clinical Trial Overview of University of Leipzig 39
Five Key Clinical Profiles 40
Appendix 59
Abbreviations 59
Definitions 59
Research Methodology 60
Secondary Research 60
About GlobalData 61
Contact Us 61
Disclaimer 61
Source 61

List of Tables

Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics, Global, Clinical Trials by Region, 2014* 7
Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics Clinical Trials, Europe, Top Countries, 2014* 10
Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics Clinical Trials, North America, Top Countries, 2014* 11
Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 12
Proportion of Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) to Immunology Clinical Trials, G7 Countries (%), 2014* 13
Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 14
Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 15
Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics, Global, Clinical Trials by Phase, 2014* 16
Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 17
Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics, Global, Clinical Trials by Trial Status, 2014* 18
Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics Clinical Trials, Global, by End Point Status, 2014* 19
Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics, Global, Terminated Clinical Trials, 2014* 20
Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 21
Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 22
Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 23
Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 24
Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 25
Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics Clinical Trials Market, Global, Clinical Trials by Celgene Corporation, 2014* 26
Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics Clinical Trials Market, Global, Clinical Trials by Astion Pharma A/S, 2014* 27
Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics Clinical Trials Market, Global, Clinical Trials by Amgen Inc., 2014* 28
Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics Clinical Trials Market, Global, Clinical Trials by Rigel Pharmaceuticals, Inc., 2014* 29
Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics Clinical Trials Market, Global, Clinical Trials by Immunomedics, Inc., 2014* 30
Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics Clinical Trials Market, Global, Clinical Trials by Department of Health, South Africa, 2014* 31
Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics Clinical Trials Market, Global, Clinical Trials by Florida Academic Dermatology Centers, 2014* 32
Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics Clinical Trials Market, Global, Clinical Trials by The Newcastle upon Tyne Hospitals NHS Foundation Trust, 2014* 33
Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics Clinical Trials Market, Global, Clinical Trials by Shahid Beheshti University of Medical Sciences, 2014* 34
Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics Clinical Trials Market, Global, Clinical Trials by The Cleveland Clinic, 2014* 35
Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics Clinical Trials Market, Global, Clinical Trials by Wake Forest University, 2014* 36
Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics Clinical Trials Market, Global, Clinical Trials by New York University School of Medicine, 2014* 37
Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2014* 38
Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Leipzig, 2014* 39

List of Figures
Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics Clinical Trials, Europe, Top Countries (%), 2014* 10
Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 11
Proportion of Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) to Immunology Clinical Trials, G7 Countries (%), 2014* 13
Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 14
Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 15
Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics, Global, Clinical Trials by Phase (%), 2014* 16
Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 17
Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics, Global, Clinical Trials by Trial Status, 2014* 18
Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics Clinical Trials, Global, by End Point Status, 2014* 19
Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 21
Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 22
Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 23
Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 24
Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 25
GlobalData Methodology 60

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Phototherapy Equipment Market by Type, Application, End-user, Geography - Global Forecast to 2021

Phototherapy Equipment Market by Type, Application, End-user, Geography - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global phototherapy equipment market is projected to reach USD 583.4 million by 2021, growing at a CAGR of 4.5% during the forecast period of 2016 to 2021. This market is primarily driven by the huge ...

Antinuclear Antibody Test Market by Product, Technique, Disease, End User - Forecast to 2021

Antinuclear Antibody Test Market by Product, Technique, Disease, End User - Forecast to 2021

  • $ 5650
  • Industry report
  • September 2016
  • by MarketsandMarkets

The global antinuclear antibody (ANA) testing market is expected to reach USD 1,476.1 million by 2021 from USD 823.5 million in 2016, at a CAGR of 12.4%. The global ANA testing market is segmented based ...

Interstitial Cystitis  - Market Insights, Epidemiology and Market Forecast-2023

Interstitial Cystitis  - Market Insights, Epidemiology and Market Forecast-2023

  • $ 4950
  • Industry report
  • November 2016
  • by Delve Insight

Note*: This report requires 5 business days to complete. DelveInsight’s Interstitial Cystitis - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.